Vanguard Group’s Entrada Therapeutics TRDA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $10.8M | Buy |
|
|||||
|
2025
Q1 | $14.2M | Buy |
|
|||||
|
2024
Q4 | $25.3M | Buy |
|
|||||
|
2024
Q3 | $19.5M | Buy |
|
|||||
|
2024
Q2 | $16.1M | Buy |
|
|||||
|
2024
Q1 | $15.3M | Buy |
|
|||||
|
2023
Q4 | $16.1M | Buy |
|
|||||
|
2023
Q3 | $16.1M | Buy |
|
|||||
|
2023
Q2 | $15.3M | Buy |
|
|||||
|
2023
Q1 | $13.5M | Buy |
|
|||||
|
2022
Q4 | $12.4M | Buy |
|
|||||
|
2022
Q3 | $13.7M | Buy |
|
|||||
|
2022
Q2 | $9.29M | Buy |
|
|||||
|
2022
Q1 | $4.04M | Buy |
|
|||||
|
2021
Q4 | $7.27M | Buy |
|